BDNF and amyotrophic lateral sclerosis: Despite a discouraging history of human trials with neurotrophins in ALS, recent works have hypothesized a role of dysregulated neurotrophin signaling in ALS etiopathogenesis (Baloh et al., 2022; Li et al., 2022).